PB2031: CD269, CD319 EXPRESSION ON MALIGNANT PLASMA CELLS AND SOLUBLE BCMA, SLAMF7 PROTEINS COMPARATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS

• A. Startsev,
• M. Solovev,
• V. Dvirnyk,
• M. Panasenko,
• I. Galtseva,
• N. Kapranov,
• M. Firsova,
• E. Makunina,
• A. Abakumova,
• E. Mamaeva,
• L. Mendeleeva

Affiliations

A. Startsev

1 National Medical Research Center for Hematology, Moscow, Russian Federation (Russia), Moscow, Russia

M. Solovev

1 National Medical Research Center for Hematology, Moscow, Russian Federation (Russia), Moscow, Russia

V. Dvirnyk

1 National Medical Research Center for Hematology, Moscow, Russian Federation (Russia), Moscow, Russia

M. Panasenko

1 National Medical Research Center for Hematology, Moscow, Russian Federation (Russia), Moscow, Russia

I. Galtseva

1 National Medical Research Center for Hematology, Moscow, Russian Federation (Russia), Moscow, Russia

N. Kapranov

1 National Medical Research Center for Hematology, Moscow, Russian Federation (Russia), Moscow, Russia

M. Firsova

1 National Medical Research Center for Hematology, Moscow, Russian Federation (Russia), Moscow, Russia

E. Makunina

1 National Medical Research Center for Hematology, Moscow, Russian Federation (Russia), Moscow, Russia

A. Abakumova

1 National Medical Research Center for Hematology, Moscow, Russian Federation (Russia), Moscow, Russia

E. Mamaeva

1 National Medical Research Center for Hematology, Moscow, Russian Federation (Russia), Moscow, Russia

L. Mendeleeva

1 National Medical Research Center for Hematology, Moscow, Russian Federation (Russia), Moscow, Russia